Moviprep and Zolpidem drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Moviprep (ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate) and Zolpidem (zolpidem tartrate). Common drug interactions include abdominal pain upper among females and renal failure among males.

The phase IV clinical study analyzes what interactions people have when they take Moviprep and Zolpidem. It is created by eHealthMe based on reports of 87 people who take the same drugs from the FDA, and is updated regularly.

What is Moviprep?

Moviprep has active ingredients of ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate. It is often used in colonoscopy abnormal. eHealthMe is studying from 3,173 Moviprep users. Check the latest studies of Moviprep.

What is Zolpidem?

Zolpidem has active ingredients of zolpidem tartrate. It is often used in insomnia. eHealthMe is studying from 92,695 Zolpidem users. Check the latest studies of Zolpidem.

On Jul, 08, 2026

87 people who take Moviprep and Zolpidem together, and have interactions are studied.

Moviprep and Zolpidem drug interactions.

What are the common drug interactions of Moviprep and Zolpidem, by gender? *:

female:

Abdominal pain upper
Anaemia (lack of blood)
Constipation
Decreased appetite
Dehydration (dryness resulting from the removal of water)
Depressed mood
Diarrhoea haemorrhagic (bloody diarrhoea)
Dizziness
Dry mouth
Dry skin

male:

Renal failure (kidney dysfunction)
Cardiac failure
Femoral artery occlusion (obstruction in artery of femur)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Nephrogenic anaemia (anaemia due to kidney disease)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Pneumonia
Somnolence (a state of near-sleep, a strong desire for sleep)
Malaise (a feeling of general discomfort or uneasiness)
Pyrexia (fever)

What are the common drug interactions of Moviprep and Zolpidem, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Chronic kidney disease
Renal failure (kidney dysfunction)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Nephrogenic anaemia (anaemia due to kidney disease)
Optic ischaemic neuropathy (optic nerve damage due to lack of blood supply)
Optic neuritis (optic nerve inflammation)
Renal injury (kidney injury)
Alanine aminotransferase increased
Aspartate aminotransferase increased
Face oedema (swelling of face)

50-59:

Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Nephritic syndrome (a collection of signs (known as a syndrome) associated with disorders affecting the kidneys, more specifically glomerular disorders)
Renal impairment (severely reduced kidney function)
C-reactive protein increased
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Drug ineffective
Haematochezia (passage of stools containing blood)
Leukocytosis (increased white blood cells)
Renal injury (kidney injury)

60+:

Hypokalaemia (low potassium)
Somnolence (a state of near-sleep, a strong desire for sleep)
Anaemia (lack of blood)
Constipation
Decreased appetite
Diarrhoea haemorrhagic (bloody diarrhoea)
Dizziness
Dry mouth
Dry skin
Dyspepsia (indigestion)

What are the existing conditions these people have? *

High Blood Pressure: 30 people, 34.48%
Stress And Anxiety: 25 people, 28.74%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 22 people, 25.29%
Pain: 21 people, 24.14%
Sleep Disorder: 18 people, 20.69%
High Blood Cholesterol: 16 people, 18.39%
Nausea (feeling of having an urge to vomit): 15 people, 17.24%
Diarrhea: 14 people, 16.09%
Hypokalemia (low potassium): 14 people, 16.09%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 13 people, 14.94%

* Approximation only. Some reports may have incomplete information.

Do you take Moviprep and Zolpidem?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously